Detailed Coverage

Sudarshan Chemical Reports Strong Revenue Growth Post-Heubach Acquisition

Consolidated Revenue: ₹9,787 Cr
Consolidated EBITDA: ₹590 Cr

Reader Takeaway: Inorganic growth drives revenue; track synergy realization and profit stabilization.

What just happened

Sudarshan Chemical Industries has reported its financial results for the year ended March 31, 2026. The company's consolidated revenue surged to ₹9,787 crore, a significant increase from ₹3,346 crore in the previous fiscal year. This growth is primarily attributed to the full-year impact of the Heubach Group acquisition. Consolidated business EBITDA (excluding other income) rose to ₹590 crore from ₹381 crore in FY 2025.

On a standalone basis, revenue from operations was ₹2,397 crore, a slight decrease from ₹2,534 crore in FY 2025. However, standalone profit after tax more than doubled to ₹290 crore from ₹141 crore in the prior year.

Why this matters

The results indicate Sudarshan Chemical's expanded scale following the Heubach acquisition, transforming it into a global player with 19 manufacturing facilities across 11 countries. Investors will be keen to see how the company integrates these operations and translates the increased revenue into sustainable profitability. The recommended final dividend of ₹5.00 per equity share signals confidence, subject to shareholder approval.

The backstory

The acquisition of the Heubach Group, completed in March 2025, marked a significant strategic move for Sudarshan Chemical. The integration process aims to unify three legacy businesses – Sudarshan, Heubach, and Clariant’s pigment unit – into a single entity named 'ONE Sudarshan'. Management noted that customer inventory destocking affected performance in the early quarters of FY26, with demand recovering by the fourth quarter.

What changes now

Sudarshan Chemical now operates at a much larger global scale. Key focus areas include system harmonization through 'Project Integra' and the establishment of a Global Capability Center in Pune to drive operational efficiencies. The company's net debt stood at ₹755 crore as of March 31, 2026, indicating a continued focus on balance sheet management.

Risks to watch

Key risks include the successful integration of the acquired Heubach business, managing customer inventory cycles, and realizing operational synergies. Achieving consistent profitability across the expanded consolidated operations will be crucial.

Peer comparison

Sudarshan Chemical is now a significant global player in the pigments industry, competing with other major international chemical companies. Its expanded footprint and product portfolio position it against established global competitors in specialty chemicals.

Context metrics (time-bound)

Consolidated Revenue FY26: ₹9,787 Cr (vs. ₹3,346 Cr in FY25)
Consolidated EBITDA FY26: ₹590 Cr (vs. ₹381 Cr in FY25)
Standalone Profit After Tax FY26: ₹290 Cr (vs. ₹141 Cr in FY25)
Net Debt as of March 31, 2026: ₹755 Cr

What to track next

Investors should monitor the company's progress in achieving integration synergies, improving consolidated profit margins, and managing its debt levels. The performance of the acquired Heubach business in the upcoming quarters will be a key indicator.